Equities

Medicure Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Medicure Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)1.12
  • Today's Change0.00 / 0.00%
  • Shares traded6.00k
  • 1 Year change+39.13%
  • Beta0.9551
Data delayed at least 15 minutes, as of Feb 12 2026 18:44 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments7.196.374.86
Total Receivables, Net5.304.795.64
Total Inventory3.282.903.22
Prepaid expenses0.131.141.13
Other current assets, total----0
Total current assets161515
Property, plant & equipment, net0.960.741.19
Goodwill, net3.383.103.18
Intangibles, net9.358.9411
Long term investments------
Note receivable - long term------
Other long term assets0.100.080.06
Total assets302830
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.370.320.35
Other current liabilities, total0.100.020.92
Total current liabilities8.407.938.39
Total long term debt0.510.230.50
Total debt0.870.540.85
Deferred income tax------
Minority interest------
Other liabilities, total----0
Total liabilities8.908.168.89
SHAREHOLDERS EQUITY
Common stock818181
Additional paid-in capital111110
Retained earnings (accumulated deficit)(67)(66)(65)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(4.26)(5.99)(5.46)
Total equity212021
Total liabilities & shareholders' equity302830
Total common shares outstanding101010
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.